David R. McAvoy - Oct 2, 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
Gen Counsel, CCO, & Secretary
Signature
/s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
Stock symbol
FRTX
Transactions as of
Oct 2, 2023
Transactions value $
-$7,209
Form type
4
Date filed
10/4/2023, 09:40 PM
Previous filing
Jan 26, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Options Exercise +20K +584.97% 23.4K Oct 2, 2023 Direct F1, F2, F3, F4
transaction FRTX Common Stock Tax liability -$7.21K -7.36K -31.42% $0.98 16.1K Oct 2, 2023 Direct F5
holding FRTX Common Stock 310 Oct 2, 2023 By spouse F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Restricted Stock Units Options Exercise $0 -20K -100% $0.00* 0 Oct 2, 2023 Common Stock 20K Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David R. McAvoy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted on January 24, 2023 and were subject to accelerated vesting as of the date of the reporting person's termination pursuant to his employment agreement with the issuer.
F2 Each restricted stock unit converted into common stock on a one-for-one basis.
F3 This balance includes 555 shares purchased under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan that were not previously reported.
F4 On July 5, 2022, the registrant effected a 1-for-45 reverse stock split ("Reverse Stock Split") of its common stock. The number of shares beneficially owned has been adjusted to give effect to the Reverse Stock Split.
F5 Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
F6 The restricted stock units vested in full on October 2, 2023.